362 related articles for article (PubMed ID: 15795933)
1. Reduced CSF PLTP activity in Alzheimer's disease and other neurologic diseases; PLTP induces ApoE secretion in primary human astrocytes in vitro.
Vuletic S; Peskind ER; Marcovina SM; Quinn JF; Cheung MC; Kennedy H; Kaye JA; Jin LW; Albers JJ
J Neurosci Res; 2005 May; 80(3):406-13. PubMed ID: 15795933
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid lipoproteins in Alzheimer's disease.
Bassett CN; Montine KS; Neely MD; Swift LL; Montine TJ
Microsc Res Tech; 2000 Aug; 50(4):282-6. PubMed ID: 10936881
[TBL] [Abstract][Full Text] [Related]
3. Statins of different brain penetrability differentially affect CSF PLTP activity.
Vuletic S; Riekse RG; Marcovina SM; Peskind ER; Hazzard WR; Albers JJ
Dement Geriatr Cogn Disord; 2006; 22(5-6):392-8. PubMed ID: 16960448
[TBL] [Abstract][Full Text] [Related]
4. Genetic association between PLTP gene polymorphisms and Alzheimer's disease in a Japanese population.
Kuerban B; Shibata N; Komatsu M; Ohnuma T; Arai H
Dement Geriatr Cogn Disord; 2010; 30(1):78-82. PubMed ID: 20714154
[TBL] [Abstract][Full Text] [Related]
5. Cerebral small vessel disease-induced apolipoprotein E leakage is associated with Alzheimer disease and the accumulation of amyloid beta-protein in perivascular astrocytes.
Utter S; Tamboli IY; Walter J; Upadhaya AR; Birkenmeier G; Pietrzik CU; Ghebremedhin E; Thal DR
J Neuropathol Exp Neurol; 2008 Sep; 67(9):842-56. PubMed ID: 18716559
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E activates the low-activity form of human phospholipid transfer protein.
Jänis MT; Metso J; Lankinen H; Strandin T; Olkkonen VM; Rye KA; Jauhiainen M; Ehnholm C
Biochem Biophys Res Commun; 2005 May; 331(1):333-40. PubMed ID: 15845396
[TBL] [Abstract][Full Text] [Related]
7. Astrocyte lipoproteins, effects of apoE on neuronal function, and role of apoE in amyloid-beta deposition in vivo.
Fagan AM; Holtzman DM
Microsc Res Tech; 2000 Aug; 50(4):297-304. PubMed ID: 10936884
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein C-I expression in the brain in Alzheimer's disease.
Petit-Turcotte C; Stohl SM; Beffert U; Cohn JS; Aumont N; Tremblay M; Dea D; Yang L; Poirier J; Shachter NS
Neurobiol Dis; 2001 Dec; 8(6):953-63. PubMed ID: 11741391
[TBL] [Abstract][Full Text] [Related]
9. Differences in the Abeta40/Abeta42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype.
Fagan AM; Younkin LH; Morris JC; Fryer JD; Cole TG; Younkin SG; Holtzman DM
Ann Neurol; 2000 Aug; 48(2):201-10. PubMed ID: 10939571
[TBL] [Abstract][Full Text] [Related]
10. Macrophage phospholipid transfer protein deficiency and ApoE secretion: impact on mouse plasma cholesterol levels and atherosclerosis.
Liu R; Hojjati MR; Devlin CM; Hansen IH; Jiang XC
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):190-6. PubMed ID: 17038631
[TBL] [Abstract][Full Text] [Related]
11. Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo.
Darreh-Shori T; Forsberg A; Modiri N; Andreasen N; Blennow K; Kamil C; Ahmed H; Almkvist O; Långström B; Nordberg A
Neurobiol Aging; 2011 Dec; 32(12):2320.e15-32. PubMed ID: 20538374
[TBL] [Abstract][Full Text] [Related]
12. Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease.
Ewers M; Zhong Z; Bürger K; Wallin A; Blennow K; Teipel SJ; Shen Y; Hampel H
Brain; 2008 May; 131(Pt 5):1252-8. PubMed ID: 18334538
[TBL] [Abstract][Full Text] [Related]
13. Increased levels of neuronal thread protein in cerebrospinal fluid of patients with Alzheimer's disease.
de la Monte SM; Volicer L; Hauser SL; Wands JR
Ann Neurol; 1992 Dec; 32(6):733-42. PubMed ID: 1471863
[TBL] [Abstract][Full Text] [Related]
14. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K
Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606
[TBL] [Abstract][Full Text] [Related]
15. CSF lipoproteins and Alzheimer's disease.
Neely MD; Montine TJ
J Nutr Health Aging; 2002; 6(6):383-91. PubMed ID: 12459889
[TBL] [Abstract][Full Text] [Related]
16. Widespread distribution of PLTP in human CNS: evidence for PLTP synthesis by glia and neurons, and increased levels in Alzheimer's disease.
Vuletic S; Jin LW; Marcovina SM; Peskind ER; Moller T; Albers JJ
J Lipid Res; 2003 Jun; 44(6):1113-23. PubMed ID: 12671035
[TBL] [Abstract][Full Text] [Related]
17. Cell-associated and extracellular phospholipid transfer protein in human coronary atherosclerosis.
O'Brien KD; Vuletic S; McDonald TO; Wolfbauer G; Lewis K; Tu AY; Marcovina S; Wight TN; Chait A; Albers JJ
Circulation; 2003 Jul; 108(3):270-4. PubMed ID: 12835223
[TBL] [Abstract][Full Text] [Related]
18. Altered kallikrein 7 and 10 concentrations in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.
Diamandis EP; Scorilas A; Kishi T; Blennow K; Luo LY; Soosaipillai A; Rademaker AW; Sjogren M
Clin Biochem; 2004 Mar; 37(3):230-7. PubMed ID: 14972646
[TBL] [Abstract][Full Text] [Related]
19. [Characterization of sialo-apolipoprotein E in human cerebrospinal fluid].
Yamauchi K
Rinsho Byori; 2009 May; 57(5):436-44. PubMed ID: 19522249
[TBL] [Abstract][Full Text] [Related]
20. Plasma apolipoprotein E concentration is an important determinant of phospholipid transfer protein activity in type 2 diabetes mellitus.
Tan KC; Shiu SW; Wong Y; Wong WK; Tam S
Diabetes Metab Res Rev; 2006; 22(4):307-12. PubMed ID: 16389649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]